AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment EP News Bureau Aug 4, 2020 I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…
